I am interested how others see this. In my view the three other players have one interest and that is to get their hands on the phosphate deposit. Avenira may be seen as a necessary means to an end - FIRB maybe wouldn’t allow them to gain control of the asset directly. I’m not sure they see Avenira as a company or management team that adds much value for them but they deal through them because they have to?
- Forums
- ASX - By Stock
- AEV
- Ann: Extension of Voluntary Suspension
Ann: Extension of Voluntary Suspension, page-25
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $29.74M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $14.12K | 1.311M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2012302 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 996420 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2012302 | 0.010 |
5 | 2188496 | 0.009 |
6 | 620000 | 0.008 |
5 | 2142142 | 0.007 |
8 | 21007328 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 996420 | 4 |
0.012 | 528673 | 4 |
0.013 | 704703 | 4 |
0.014 | 2290000 | 4 |
0.015 | 2500000 | 3 |
Last trade - 14.30pm 15/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online